Imported Mollusks and Dissemination of Human Enteric Viruses
To the Editor: The globalization of food production and trade has increased the potential risk for infectious foodborne diseases. Hepatitis A virus (HAV) and norovirus (NoV) constitute the most important foodborne pathogens of humans in terms of numbers of outbreaks and persons affected in industrialized countries (1, 2) . In these countries, improvement of health conditions and development of specifi c vaccines are changing the epidemiologic pattern of diseases such as hepatitis A, decreasing their prevalence and increasing the susceptibility of the unvaccinated adult population (1) . In recent years, numerous cases of gastroenteritis caused by NoV and hepatitis A linked to imported shellfi sh have been reported (2) (3) (4) (5) . In Spain, 2 notable hepatitis A outbreaks associated with clams (Donax sp.) imported from Peru occurred in 1999 and 2008. In both situations, the Spanish Ministry of Health activated the National System of Epidemiologic Surveillance and the European Community Rapid Alert System for Foodstuffs. The implicated shellfi sh batches were immobilized or removed, and all the shellfi sh from Peru were banned from the European Union (6). We present further evidence that imported shellfi sh from developing countries, where these pathogens are endemic, can be a vehicle for viral gastroenteritis and HAV infections in areas where they are not endemic.
Fifty mollusk samples imported into Spain during September 2006-March 2009 were analyzed for NoV genotype I (GI) and GII, HAV and astrovirus (AsV). Countries of origin were Morocco, Peru, Vietnam, and South Korea (Table) . The species studied were clams (Callista chione, n = 25; Transanella pannosa, n = 6; Meretrix lyrata, n = 3; and Donax sp., n = 5), oysters (Crassostrea angulata, n = 1), cockles (Cerastoderma edule, n = 1), and razor clams (Solen marginatus, n = 1 and Ensis sp., n = 8). Digestive tissue was dissected from duplicated samples (10-20 individual mollusks) and homogenized with 0.1% peptone water (pH 7.4), centrifuged at 1,000 × g for 5 min, and supernatant recovered. RNA was extracted by using both Total Quick RNA extraction Cells and Tissue kit (Talent, Trieste, Italy) and Nucleospin RNA Virus Kit (Macherey-Nagel, Düren, Germany).
NoV and HAV were detected by real-time reverse transcription-PCR (RT-PCR) by using the Platinum Quantitative RT-PCR Thermoscript 1-step system (Invitrogen, Carlsbad, CA, USA) (25 μL fi nal volume) with 5 μL of template RNA, and primers, probes, and conditions as described (7) . A sample that displayed a cycle threshold value <41 was considered positive. AsV was detected by standard RT-PCR (7), coupled with hybridization by using specifi c biotinlabeled probes with the commercial Kit Hybridowell universal (Argene, Varilhes, France).
Negative and specifi c positive controls for HAV, NoV, and AsV were introduced in each run. Real-time RT-PCR included appropriate external controls in each analysis to avoid underestimation of viral load. A mutant, nonvirulent, infective strain of mengovirus (vMC 0 ) (10 3 PFU) was used as control for extraction. To calculate the real-time RT-PCR effi ciencies, external viral RNA (HAV, 10 3 copies) or synthetic DNA (NoV, 10 5 copies) controls for the respective virus were co-amplifi ed with each template viral RNA as described (8) . The number of RNA viral genome copies per gram of digestive tissue (RNA copies/g digestive tissue) was estimated by using standard curves generated from RNA transcripts and synthetic DNA (8) and corrected with the extraction and realtime RT-PCR effi ciencies.
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Twenty (40%) of 50 samples were contaminated by >1 virus (Table) , although all the mollusk imports complied with the current sanitary standards. NoV GI was most prevalent, detected in 24% of samples, followed by AsV (18%), NoV GII (8%), and HAV (4%). One sample showed a low extraction effi ciency (<1%), yielding all samples high real-time RT-PCR effi ciencies (>10%) (9).
Six samples (30% of positive samples) were positive for >1 virus. Thus, 2 samples from Morocco showed contamination with NoV GI and AsV. From Peru, 1 sample was contaminated with both genogroups of NoV and another with NoV GI, NoV GII, and AsV. Samples from Vietnam (n = 2) were contaminated with HAV-NoV GI and NoV GIAsV. Co-infection with different viruses or multiple virus strains could lead to more severe symptoms and the occurence of 2 episodes of the same or different diseases and also be a way to facilitate emergence of new recombinant strains (10).
Contamination levels for NoV GI ranged from 3. RNA copies/g digestive tissue (Table) . For HAV, these values are in the same range or even higher than in the coquina clams from Peru implicated in the outbreak in Spain in 2008, which is noteworthy because the attack rate for different batches of shellfi sh is dose dependent (6) .
Determining the association of a viral infection with a particular contaminated product is often complicated, and the epidemiologic investigations necessary for fi nding this association are time consuming and allow the virus to spread before the problem is recognized. Furthermore, there are analytical diffi culties in detecting and quantifying virus in shellfi sh samples and in monitoring them; other problems include ascertaining the representativeness of the sample (2,6) and the high cost of applying the technique in areas with extensive mollusk production.
The inadequacy of the bacterial indicators makes it necessary to develop new prevention strategies, based on microbial risk assessment, to ensure the sanitary quality of shellfi sh, both in production areas and in international trade operations. Implementing these methods and providing training to laboratories in developing countries are essential to achieving these objectives. To the Editor: Chikungunya fever was fi rst described in Tanganyika (now Tanzania) in 1952 and is now emerging in Southeast Asia. Chikungunya virus (CHIKV) infection, a self-limiting febrile illness, shares similarities with dengue fever such as headache and myalgia. Additionally, patients with CHIKV infection typically have arthralgia, arthritis, and tenosynovitis (1). Although usually benign, CHIKV infection may on rare occasions lead to neurologic and hepatic manifestations with high illness and mortality rates (2). We report 2 immunocompromised patients with CHIKV infection associated with peritonitis, encephalitis, and secondary bacterial infections.
Patient A, a 66-year-old Singaporean-Chinese man, had a history of chronic renal disease secondary to obstructive uropathy. His baseline creatinine level was 300-400 μmol/L. For 3 years, he had ingested traditional Chinese medicine, which we suspect was contaminated by steroids because he appeared cushingoid. An outbreak of CHIKV infection was reported at his workplace. He was admitted to National University Hospital, Singapore, in July 2008 with abdominal pain, vomiting, and fever of 1 day. He had no joint symptoms. Clinically, he had systemic infl ammatory response syndrome complicated by acute-on-chronic renal failure. His creatinine level was elevated at 921 μmol/L on admission. A complete blood count showed leukocytosis (19.24 × 10 9 cells/L) with neutrophilia and thrombocytopenia (62 × 10 9 cells/L). Initial blood and urine cultures and serologic results were negative for dengue virus, but serum reverse transcription-PCR (RT-PCR) and indirect immunofl uorescent assay for immunoglobulin G (IgG) (Euroimmun Medizinische Labordiagnostika, Lubeck, Germany) and IgM (CTK Biotech, Inc, San Diego, CA, USA) were positive for CHIKV (3, 4) . Computed tomographic scans of the abdomen showed dilated small bowel loops.
An urgent laparotomy did not show bowel perforation, but peritoneal cultures yielded Klebsiella pneumoniae, Escherichia coli, and Candida glabrata, and RT-PCR from the concentrated peritoneal fl uid was positive for CHIKV (3) . He was administered appropriate antimicrobial drugs. He required repeat laparotomies because of elevated intraabdominal pressure. He subsequently received broad spectrum antimicrobial drugs to treat secondary intraabdominal infections caused by P. aeruginosa and Enterococcus faecalis.
Ventilator-associated pneumonia also developed. Despite maximal support and prolonged antimicrobial therapy, this patient died after 5 months of hospitalization.
Patient B, a 45-year-old Malaysian-Chinese man with diabetes mellitus, had undergone a cadaveric liver transplant in 2001 for hepatitis B liver cirrhosis. He was receiving immunosuppressants (azathioprine and prednisolone). He was admitted in August 2008 after experiencing fever, headache, and abdominal bloating for 3 days. He had no neurologic symptoms. Acute self-limiting febrile illnesses with arthritis had occurred in his hometown; CHIKV infections were suspected.
Results of his examination on admission were normal, except for bilateral enlarged cervical lymph nodes. Chest radiograph results were unremarkable. He had mild transaminitis (alanine aminotransferase 173 U/L, aspartate aminotransferase 170 U/L), elevated C-reactive protein (107 mg/L), and thrombocytopenia (120 × 10 9 cells/L) without leukocytosis. Results of comprehensive serum and urine microbial studies were negative for posttransplant infections. Results of serum RT-PCR were negative for CHIKV, but IgG and IgM tests were positive for CHIKV.
Brain magnetic resonance imaging was performed because of the patient's persistent severe headache and transient drowsiness. It showed several nonspecifi c areas of enhancement, which suggested encephalitis, given the clinical scenario (Figure) . However, a lumbar puncture was not performed, and hence, whether the patient's cerebrospinal fl uid contained CHIKV could not be determined. Bilateral frontoparietal white matter lesions with restricted diffusion has been suggested as an early sign of viral encephalitis (5). However, a retrospective series demonstrated that, in CHIKV encephalitis, abnormalities on magnetic resonance imaging were uncommon, and no pathognomonic features were found (6) .
Hospital-acquired pneumonia also developed and was treated with broadspectrum antimicrobial drugs. Bron-
